11900 related articles for article (PubMed ID: 10025678)
1. Tracers for imaging melanin with positron emission tomography.
Sadzot B; Sheldon J; Flesher J; Dannals RF; Schachat AP; Frost JJ
Synapse; 1999 Jan; 31(1):5-12. PubMed ID: 10025678
[TBL] [Abstract][Full Text] [Related]
2. Studies on the melanin affinity of haloperidol.
Lydén A; Larsson B; Lindquist NG
Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):230-43. PubMed ID: 7181580
[TBL] [Abstract][Full Text] [Related]
3. Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.
Mansard S; Papon J; Moreau MF; Miot-Noirault E; Labarre P; Bayle M; Veyre A; Madelmont JC; Moins N
Nucl Med Biol; 2005 Jul; 32(5):451-8. PubMed ID: 15982575
[TBL] [Abstract][Full Text] [Related]
4. A critical review of the function of neuromelanin and an attempt to provide a unified theory.
Nicolaus BJ
Med Hypotheses; 2005; 65(4):791-6. PubMed ID: 15949901
[TBL] [Abstract][Full Text] [Related]
5. Studies on the melanin affinity of selegiline (deprenyl) and other amphetamine derivatives.
Báthory G; Szüts T; Magyar K
Pol J Pharmacol Pharm; 1987; 39(2):195-201. PubMed ID: 3124086
[TBL] [Abstract][Full Text] [Related]
6. Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy.
Karlsson O; Berg C; Brittebo EB; Lindquist NG
Pigment Cell Melanoma Res; 2009 Feb; 22(1):120-30. PubMed ID: 19154235
[TBL] [Abstract][Full Text] [Related]
7. Properties of the melanin binding of p-bromo-methylamphetamine (V-111).
Báthory G; Szökö E; Magyar K; Deutsch T
Pol J Pharmacol Pharm; 1990; 42(1):19-27. PubMed ID: 2281018
[TBL] [Abstract][Full Text] [Related]
8. Binding of 14C-spermidine to melanin in vivo and in vitro.
Tjälve H; Nilsson M; Larsson B
Acta Physiol Scand; 1981 Jun; 112(2):209-14. PubMed ID: 7315415
[TBL] [Abstract][Full Text] [Related]
9. Absence of strial melanin coincides with age-associated marginal cell loss and endocochlear potential decline.
Ohlemiller KK; Rice ME; Lett JM; Gagnon PM
Hear Res; 2009 Mar; 249(1-2):1-14. PubMed ID: 19141317
[TBL] [Abstract][Full Text] [Related]
10. Correlation between rod photoreceptor numbers and levels of ocular pigmentation.
Donatien P; Jeffery G
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1198-203. PubMed ID: 11923266
[TBL] [Abstract][Full Text] [Related]
11. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and first in vivo evaluation of new selective high affinity beta1-adrenoceptor radioligands for SPECT based on ICI 89,406.
Wagner S; Kopka K; Law MP; Riemann B; Pike VW; Schober O; Schäfers M
Bioorg Med Chem; 2004 Aug; 12(15):4117-32. PubMed ID: 15246089
[TBL] [Abstract][Full Text] [Related]
13. Brain radioligands--state of the art and new trends.
Halldin C; Gulyás B; Langer O; Farde L
Q J Nucl Med; 2001 Jun; 45(2):139-52. PubMed ID: 11476163
[TBL] [Abstract][Full Text] [Related]
14. Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats.
Lourenco CM; DaSilva JN; Warsh JJ; Wilson AA; Houle S
Synapse; 1999 Jan; 31(1):41-50. PubMed ID: 10025682
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
Evens N; Muccioli GG; Houbrechts N; Lambert DM; Verbruggen AM; Van Laere K; Bormans GM
Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
[TBL] [Abstract][Full Text] [Related]
16. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM
Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471
[TBL] [Abstract][Full Text] [Related]
17. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
Gao M; Mock BH; Hutchins GD; Zheng QH
Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
[TBL] [Abstract][Full Text] [Related]
19. Binding of drugs to eye melanin is not predictive of ocular toxicity.
Leblanc B; Jezequel S; Davies T; Hanton G; Taradach C
Regul Toxicol Pharmacol; 1998 Oct; 28(2):124-32. PubMed ID: 9927562
[TBL] [Abstract][Full Text] [Related]
20. Melanin content of hamster tissues, human tissues, and various melanomas.
Watts KP; Fairchild RG; Slatkin DN; Greenberg D; Packer S; Atkins HL; Hannon SJ
Cancer Res; 1981 Feb; 41(2):467-72. PubMed ID: 7448793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
